risk management improves decision making if a quality problem arises. It should include systemic processes designated to co-ordinate, facilitate and improve science-based decision-making with respect to risk ... applied…
Mishal A Altamimi, Sami Alsager, Ibrahim Alshowaier
Pharmaceuticals, cosmetics, medical device and food were scattered between different government organizations before the establishments of the Saudi Food and Drug Authority (SFDA) in 2004. It took the SFDA about…
During finished pharmaceutical product (FPP), manufacturing process development following QbD (Quality by Design) and in the race to be first to file product registration, a balance is needed between effective
using selective breeding or artificial selection (as contrasted with natural selection). The process of selective breeding, in which organisms with desired traits (and thus with the desired genes) are used ... using…
case of pharmaceuticals or expression of an adverse event, the principle objective remains the same: Maintaining the integrity of information. The primary purpose of developing coding terminologies is to provide…
also increases the risk of investing in the development of wrong product which causes a huge loss to a pharmaceutical company. Therefore, it is very important to establish a robust ... pharmacovigilance data management…
Drug safety is investigated during different phases of clinical development, aimed to establish a risk-benefit ratio that allows registration and marketing. The management of drug safety during the conduct ... success…
biggest pharmaceutical market in the world and the Brazilian Heath Surveillance Agency (ANVISA) is responsible to evaluate the products quality and safety. The process of expanding access to data ... frustrate…
case of pharmaceuticals or expression of an adverse event, the principle objective remains the same: Maintaining the integrity of information. The primary purpose of developing coding terminologies is to provide…
site selection and clinical trial budget is one of the biggest challenges for bio-pharmaceutical R&D industry. Since the first trials of legumes in biblical times to the first ... order to address these issues we need…
also increases the risk of investing in the development of wrong product which causes a huge loss to a pharmaceutical company. Therefore, it is very important to establish a robust ... pharmacovigilance data management…
pharmaceutical industries to reduce chemical waste and improve the selectivity and efficiency of synthetic processes. The need to implement green chemistry principles is a driving force towards the development
process generates large amounts of by-products such as grape seeds and skins which are rich in polyphenols with strong antioxidant properties that are interesting from a chemical, pharmaceutical ... natural substances…
January 2013 and clinical cancer whole exome/transcriptome(CWES) sequencing since January 2014. We processed and issued reports on over 500constitutional and about 100 cancer cases. The majority of these ... pathogenic…